Advertisement

Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease

  • Hannibal PersonEmail author
  • Laurie Keefer
Pediatric Gastroenterology (S Orenstein and S Khan, Section Editors)
  • 11 Downloads
Part of the following topical collections:
  1. Topical Collection on Pediatric Gastroenterology

Abstract

Purpose of Review

The purpose of this review is to discuss current knowledge of brain-gut therapies (BGT) in pediatric functional gastrointestinal disorders (FGID) and inflammatory bowel disease (IBD), including their evidence base, the common psychopathology that they address, and the integration of this knowledge into medical settings.

Recent Findings

Cognitive behavioral therapy (CBT), hypnotherapy (HT), mindfulness-based therapy (MBT), and exposure-based therapy (EBT) have the most data supporting their use in children, particularly in FGID, more so than in IBD. This difference is most likely because of the increased role of psychological factors in FGID, though these same factors can be seen comorbidly in IBD. Integrative BGT treatment strategies with the collaboration of clinicians across disciplines may provide the most benefit to patients.

Summary

This review details our current understanding of the evidence for BGT in pediatric FGID and IBD and how they may best be used in treatment strategies.

Keywords

Functional gastrointestinal disorders Pediatrics Brain-gut therapies Irritable bowel syndrome Inflammatory bowel disease Psychological treatments Cognitive behavioral therapy 

Notes

Compliance with Ethical Standards

Conflict of Interest

Laurie Keefer reports personal fees from MetaMe Connect and non-financial support from Rome Foundation Board of Directors outside the submitted work.

Hannibel Person declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, et al. Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology. 2016.  https://doi.org/10.1053/j.gastro.2016.02.027. This is a review of our current understanding of the biopsychosocial mechanisms that create and maintain FGID.
  2. 2.
    Bernstein CN. The brain-gut axis and stress in inflammatory bowel disease. Gastroenterol Clin N Am. 2017;46(4):839–46.  https://doi.org/10.1016/j.gtc.2017.08.006.CrossRefGoogle Scholar
  3. 3.
    Khlevner J, Park Y, Margolis KG. Brain-gut axis: clinical implications. Gastroenterol Clin N Am. 2018;47(4):727–39.  https://doi.org/10.1016/j.gtc.2018.07.002.CrossRefGoogle Scholar
  4. 4.
    Colombel JF, Shin A, Gibson PR. Functional gastrointestinal symptoms in patients with inflammatory bowel disease; Clin Gastroenterol Hepatol. 2018.  https://doi.org/10.1016/j.cgh.2018.08.001.
  5. 5.
    • Watson KL Jr, Kim SC, Boyle BM, Saps M. Prevalence and impact of functional abdominal pain disorders in children with inflammatory bowel diseases (IBD-FAPD). J Pediatr Gastroenterol Nutr. 2017;65(2):212–7.  https://doi.org/10.1097/MPG.0000000000001479. This is the first study to use Rome III criteria to assess the prevalence of FAP in pediatric IBD, also suggesting increased prevalence of mood symptoms in children with IBD-FAP. CrossRefPubMedGoogle Scholar
  6. 6.
    Chiou E, Nurko S. Functional abdominal pain and irritable bowel syndrome in children and adolescents. Therapy. 2011;8(3):315–31.CrossRefGoogle Scholar
  7. 7.
    Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2013;56(4):449–58.  https://doi.org/10.1097/MPG.0b013e3182841263.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481–91.  https://doi.org/10.1136/gut.2005.064261.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Bonney Reed-Knight LMM, Wallace V. Crandall Psychological aspects of inflammatory bowel disease in children and adolescents. Pediatric inflammatory bowel disease. New York: Springer International Publishing; 2017. p. 615–23.Google Scholar
  10. 10.
    Levy RL, Whitehead WE, Walker LS, Von Korff M, Feld AD, Garner M, et al. Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol. 2004;99(12):2442–51.  https://doi.org/10.1111/j.1572-0241.2004.40478.x.CrossRefPubMedGoogle Scholar
  11. 11.
    Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome Axis. Cell Mol Gastroenterol Hepatol. 2018;6(2):133–48.  https://doi.org/10.1016/j.jcmgh.2018.04.003.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381–96.  https://doi.org/10.1146/annurev-med-012309-103958.CrossRefPubMedGoogle Scholar
  13. 13.
    Campo JV, Bridge J, Ehmann M, Altman S, Lucas A, Birmaher B, et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics. 2004;113(4):817–24.CrossRefGoogle Scholar
  14. 14.
    Kilroy S, Nolan E, Sarma KM. Quality of life and level of anxiety in youths with inflammatory bowel disease in Ireland. J Pediatr Gastroenterol Nutr. 2011;53(3):275–9.  https://doi.org/10.1097/MPG.0b013e318214c131.CrossRefPubMedGoogle Scholar
  15. 15.
    Reigada LC, Hoogendoorn CJ, Walsh LC, Lai J, Szigethy E, Cohen BH, et al. Anxiety symptoms and disease severity in children and adolescents with Crohn disease. J Pediatr Gastroenterol Nutr. 2015;60(1):30–5.  https://doi.org/10.1097/MPG.0000000000000552.CrossRefPubMedGoogle Scholar
  16. 16.
    Clark JG, Srinath AI, Youk AO, Kirshner MA, McCarthy FN, Keljo DJ, et al. Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2014;58(5):569–73.  https://doi.org/10.1097/MPG.0000000000000277.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Benhayon D, Youk A, McCarthy FN, Davis S, Keljo DJ, Bousvaros A, et al. Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2013;57(3):335–42.  https://doi.org/10.1097/MPG.0b013e31829641df.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Beck AT. The past and future of cognitive therapy. J Psychother Pract Res. 1997;6(4):276–84.PubMedPubMedCentralGoogle Scholar
  19. 19.
    White CA. Cognitive behavioral principles in managing chronic disease. West J Med. 2001;175(5):338–42.CrossRefGoogle Scholar
  20. 20.
    Kinsinger SW. Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights. Psychol Res Behav Manag. 2017;10:231–7.  https://doi.org/10.2147/PRBM.S120817.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Galdston MR, John RM. Mind over gut: psychosocial management of pediatric functional abdominal pain. J Pediatr Health Care. 2016;30(6):535–45.  https://doi.org/10.1016/j.pedhc.2015.11.011.CrossRefPubMedGoogle Scholar
  22. 22.
    •• Bonnert M, Olen O, Lalouni M, Hedman-Lagerlof E, Sarnholm J, Serlachius E et al. Internet-delivered exposure-based cognitive-behavioral therapy for adolescents with functional abdominal pain or functional dyspepsia: a feasibility study. Behav Ther. 2019;50(1):177–88.  https://doi.org/10.1016/j.beth.2018.05.002. This study demonstrates that internet-delivered EBT is beneficial in adolescents with FAP and FD.
  23. 23.
    Freeman KA, Riley A, Duke DC, Fu R. Systematic review and meta-analysis of behavioral interventions for fecal incontinence with constipation. J Pediatr Psychol. 2014;39(8):887–902.  https://doi.org/10.1093/jpepsy/jsu039.CrossRefPubMedGoogle Scholar
  24. 24.
    Slutsker B, Konichezky A, Gothelf D. Breaking the cycle: cognitive behavioral therapy and biofeedback training in a case of cyclic vomiting syndrome. Psychol Health Med. 2010;15(6):625–31.  https://doi.org/10.1080/13548506.2010.498893.CrossRefPubMedGoogle Scholar
  25. 25.
    van Tilburg MAL. Cognitive behavioral therapy for functional gastrointestinal disorders. In: Faure C, Thapar N, De Lorenzo C, editors. Pediatric neurogastroenterology. Cham, Springer; 2017. p. 507–13.Google Scholar
  26. 26.
    Lackner JM, Jaccard J, Radziwon CD, Firth RS, Gudleski GD, Hamilton F, et al. Durability and decay of treatment benefit of cognitive behavioral therapy for irritable bowel syndrome: 12-month follow-up. Am J Gastroenterol. 2018.  https://doi.org/10.1038/s41395-018-0396-x.
  27. 27.
    Bonnert M, Olen O, Lalouni M, Benninga MA, Bottai M, Engelbrektsson J, et al. Internet-delivered cognitive behavior therapy for adolescents with irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2017;112(1):152–62.  https://doi.org/10.1038/ajg.2016.503.CrossRefPubMedGoogle Scholar
  28. 28.
    Rathbone AL, Clarry L, Prescott J. Assessing the efficacy of mobile health apps using the basic principles of cognitive behavioral therapy: systematic review. J Med Internet Res. 2017;19(11):e399.  https://doi.org/10.2196/jmir.8598.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Szigethy E, Kenney E, Carpenter J, Hardy DM, Fairclough D, Bousvaros A, et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1290–8.  https://doi.org/10.1097/chi.0b013e3180f6341f.CrossRefPubMedGoogle Scholar
  30. 30.
    Szigethy E, Bujoreanu SI, Youk AO, Weisz J, Benhayon D, Fairclough D, et al. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2014;53(7):726–35.  https://doi.org/10.1016/j.jaac.2014.04.014.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Levy RL, van Tilburg MA, Langer SL, Romano JM, Walker LS, Mancl LA, et al. Effects of a cognitive behavioral therapy intervention trial to improve disease outcomes in children with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(9):2134–48.  https://doi.org/10.1097/MIB.0000000000000881.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    •• Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Beukers R, Korpershoek TA, et al. Effectiveness of disease-specific cognitive behavioral therapy on anxiety, depression, and quality of life in youth with inflammatory bowel disease: a randomized controlled trial. J Pediatr Psychol. 2018;43(9):967–80.  https://doi.org/10.1093/jpepsy/jsy029. The most recent randomized control trial comparing disease-specific CBT to care as usual in pediatric IBD, suggesting no difference in improving psychological symptoms or HRQOL. CrossRefPubMedGoogle Scholar
  33. 33.
    Ljotsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol. 2011;106(8):1481–91.  https://doi.org/10.1038/ajg.2011.139.CrossRefPubMedGoogle Scholar
  34. 34.
    Lalouni M, Olen O, Bonnert M, Hedman E, Serlachius E, Ljotsson B. Exposure-based cognitive behavior therapy for children with abdominal pain: a pilot trial. PLoS One. 2016;11(10):e0164647.  https://doi.org/10.1371/journal.pone.0164647.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Brugnoli MP, Pesce G, Pasin E, Basile MF, Tamburin S, Polati E. The role of clinical hypnosis and self-hypnosis to relief pain and anxiety in severe chronic diseases in palliative care: a 2-year long-term follow-up of treatment in a nonrandomized clinical trial. Ann Palliat Med. 2018;7(1):17–31.  https://doi.org/10.21037/apm.2017.10.03.CrossRefPubMedGoogle Scholar
  36. 36.
    Del Casale A, Ferracuti S, Rapinesi C, De Rossi P, Angeletti G, Sani G, et al. Hypnosis and pain perception: an activation likelihood estimation (ALE) meta-analysis of functional neuroimaging studies. J Physiol Paris. 2015;109(4–6):165–72.  https://doi.org/10.1016/j.jphysparis.2016.01.001.CrossRefPubMedGoogle Scholar
  37. 37.
    Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23(8):1241–9.  https://doi.org/10.1111/j.1365-2036.2006.02881.x.CrossRefPubMedGoogle Scholar
  38. 38.
    Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res. 2004;56(3):271–8.  https://doi.org/10.1016/S0022-3999(03)00076-X.CrossRefPubMedGoogle Scholar
  39. 39.
    Riehl ME, Keefer L. Hypnotherapy for esophageal disorders. Am J Clin Hypn. 2015;58(1):22–33.  https://doi.org/10.1080/00029157.2015.1025355.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002;123(6):1778–85.  https://doi.org/10.1053/gast.2002.37071.CrossRefPubMedGoogle Scholar
  41. 41.
    Rutten JM, Vlieger AM, Frankenhuis C, George EK, Groeneweg M, Norbruis OF, et al. Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists. BMC Pediatr. 2014;14:140.  https://doi.org/10.1186/1471-2431-14-140.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, Tromp E, Benninga MA. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology. 2007;133(5):1430–6.  https://doi.org/10.1053/j.gastro.2007.08.072.CrossRefPubMedGoogle Scholar
  43. 43.
    van Tilburg MA, Chitkara DK, Palsson OS, Turner M, Blois-Martin N, Ulshen M, et al. Audio-recorded guided imagery treatment reduces functional abdominal pain in children: a pilot study. Pediatrics. 2009;124(5):e890–7.  https://doi.org/10.1542/peds.2009-0028.CrossRefPubMedGoogle Scholar
  44. 44.
    Weydert JA, Shapiro DE, Acra SA, Monheim CJ, Chambers AS, Ball TM. Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial. BMC Pediatr. 2006;6:29.  https://doi.org/10.1186/1471-2431-6-29.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    • Vlieger AM, Rutten JM, Govers AM, Frankenhuis C, Benninga MA. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol. 2012;107(4):627–31.  https://doi.org/10.1038/ajg.2011.487. Randomized control trial suggesting that HT is more effective than supportive therapy in reducing pain and somatisization scores in pediatric FAP and IBS after 5 years of follow-up. CrossRefPubMedGoogle Scholar
  46. 46.
    Szigethy E. Hypnotherapy for inflammatory bowel disease across the lifespan. Am J Clin Hypn. 2015;58(1):81–99.  https://doi.org/10.1080/00029157.2015.1040112.CrossRefPubMedGoogle Scholar
  47. 47.
    Shaoul R, Sukhotnik I, Mogilner J. Hypnosis as an adjuvant treatment for children with inflammatory bowel disease. J Dev Behav Pediatr. 2009;30(3):268.  https://doi.org/10.1097/DBP.0b013e3181a7eeb0.CrossRefPubMedGoogle Scholar
  48. 48.
    Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013;38(7):761–71.  https://doi.org/10.1111/apt.12449.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 2008;103(6):1460–9.  https://doi.org/10.1111/j.1572-0241.2008.01845.x.CrossRefPubMedGoogle Scholar
  50. 50.
    Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract. 2006.Google Scholar
  51. 51.
    Ahola Kohut S, Stinson J, Davies-Chalmers C, Ruskin D, van Wyk M. Mindfulness-based interventions in clinical samples of adolescents with chronic illness: a systematic review. J Altern Complement Med. 2017;23(8):581–9.  https://doi.org/10.1089/acm.2016.0316.CrossRefPubMedGoogle Scholar
  52. 52.
    Korterink JJ, Ockeloen LE, Hilbink M, Benninga MA, Deckers-Kocken JM. Yoga therapy for abdominal pain-related functional gastrointestinal disorders in children: a randomized controlled trial. J Pediatr Gastroenterol Nutr. 2016;63(5):481–7.  https://doi.org/10.1097/MPG.0000000000001230.CrossRefPubMedGoogle Scholar
  53. 53.
    • Ali A, Weiss TR, Dutton A, McKee D, Jones KD, Kashikar-Zuck S, et al. Mindfulness-based stress reduction for adolescents with functional somatic syndromes: a pilot cohort study. J Pediatr. 2017;183:184–90.  https://doi.org/10.1016/j.jpeds.2016.12.053. A pilot study introducing a MBSR program to a cohort of pediatric patients with functional somatic syndromes demonstrating improvements in functional disability, symptom impact, and anxiety. CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Garland EL, Gaylord SA, Palsson O, Faurot K, Douglas Mann J, Whitehead WE. Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med. 2012;35(6):591–602.  https://doi.org/10.1007/s10865-011-9391-z.CrossRefPubMedGoogle Scholar
  55. 55.
    Gaylord SA, Whitehead WE, Coble RS, Faurot KR, Palsson OS, Garland EL, et al. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Complement Altern Med. 2009;9:24.  https://doi.org/10.1186/1472-6882-9-24.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Cotton S, Humenay Roberts Y, Tsevat J, Britto MT, Succop P, McGrady ME, et al. Mind-body complementary alternative medicine use and quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(3):501–6.  https://doi.org/10.1002/ibd.21045.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Neilson K, Ftanou M, Monshat K, Salzberg M, Bell S, Kamm MA, et al. A controlled study of a group mindfulness intervention for individuals living with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(3):694–701.  https://doi.org/10.1097/MIB.0000000000000629.CrossRefPubMedGoogle Scholar
  58. 58.
    •• Beinvogl B, Burch E, Snyder J, Schechter N, Hale A, Okazaki Y, et al. Multidisciplinary treatment of pediatric functional gastrointestinal disorders results in improved pain and functioning. Clin Gastroenterol Hepatol. 2018.  https://doi.org/10.1016/j.cgh.2018.07.025. A single-site, retrospective observational cohort study of pediatric patients with FGID demonstrating the importance of comprehensive and multidisciplinary care.
  59. 59.
    Hechler T, Kanstrup M, Holley AL, Simons LE, Wicksell R, Hirschfeld G, et al. Systematic review on intensive interdisciplinary pain treatment of children with chronic pain. Pediatrics. 2015;136(1):115–27.  https://doi.org/10.1542/peds.2014-3319.CrossRefPubMedGoogle Scholar
  60. 60.
    Lalouni M, Ljotsson B, Bonnert M, Ssegonja R, Benninga M, Bjureberg J, et al. Clinical and cost effectiveness of online cognitive behavioral therapy in children with functional abdominal pain disorders. Clin Gastroenterol Hepatol. 2018.  https://doi.org/10.1016/j.cgh.2018.11.043.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pediatrics, Division of GastroenterologyIcahn School of Medicine at Mount SinaiNew YorkUSA
  2. 2.Department of Medicine, Division of GastroenterologyIcahn School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations